385 related articles for article (PubMed ID: 29616444)
1. Magnetic Resonance Spectroscopy in Schizophrenia: Evidence for Glutamatergic Dysfunction and Impaired Energy Metabolism.
Duarte JMN; Xin L
Neurochem Res; 2019 Jan; 44(1):102-116. PubMed ID: 29616444
[TBL] [Abstract][Full Text] [Related]
2. Current Practice and New Developments in the Use of In Vivo Magnetic Resonance Spectroscopy for the Assessment of Key Metabolites Implicated in the Pathophysiology of Schizophrenia.
Dwyer GE; Hugdahl K; Specht K; Grüner R
Curr Top Med Chem; 2018; 18(21):1908-1924. PubMed ID: 30499397
[TBL] [Abstract][Full Text] [Related]
3. Glutamatergic abnormalities in schizophrenia: a review of proton MRS findings.
Poels EM; Kegeles LS; Kantrowitz JT; Javitt DC; Lieberman JA; Abi-Dargham A; Girgis RR
Schizophr Res; 2014 Feb; 152(2-3):325-32. PubMed ID: 24418122
[TBL] [Abstract][Full Text] [Related]
4. Glutamate in schizophrenia: a focused review and meta-analysis of ¹H-MRS studies.
Marsman A; van den Heuvel MP; Klomp DW; Kahn RS; Luijten PR; Hulshoff Pol HE
Schizophr Bull; 2013 Jan; 39(1):120-9. PubMed ID: 21746807
[TBL] [Abstract][Full Text] [Related]
5. Imaging the glutamate system in humans: relevance to drug discovery for schizophrenia.
Stone JM
Curr Pharm Des; 2009; 15(22):2594-602. PubMed ID: 19689330
[TBL] [Abstract][Full Text] [Related]
6. Effect of L-theanine on glutamatergic function in patients with schizophrenia.
Ota M; Wakabayashi C; Sato N; Hori H; Hattori K; Teraishi T; Ozawa H; Okubo T; Kunugi H
Acta Neuropsychiatr; 2015 Oct; 27(5):291-6. PubMed ID: 25896423
[TBL] [Abstract][Full Text] [Related]
7. 7T Proton Magnetic Resonance Spectroscopy of Gamma-Aminobutyric Acid, Glutamate, and Glutamine Reveals Altered Concentrations in Patients With Schizophrenia and Healthy Siblings.
Thakkar KN; Rösler L; Wijnen JP; Boer VO; Klomp DW; Cahn W; Kahn RS; Neggers SF
Biol Psychiatry; 2017 Mar; 81(6):525-535. PubMed ID: 27316853
[TBL] [Abstract][Full Text] [Related]
8. Increased glutamine in patients undergoing long-term treatment for schizophrenia: a proton magnetic resonance spectroscopy study at 3 T.
Bustillo JR; Chen H; Jones T; Lemke N; Abbott C; Qualls C; Canive J; Gasparovic C
JAMA Psychiatry; 2014 Mar; 71(3):265-72. PubMed ID: 24402128
[TBL] [Abstract][Full Text] [Related]
9. Using proton magnetic resonance spectroscopic imaging to study glutamatergic alterations in patients with schizophrenia: A systematic review.
Plitman E; Guma E; Lepage M; Near J; Chakravarty MM
Schizophr Res; 2019 Aug; 210():13-20. PubMed ID: 31272905
[TBL] [Abstract][Full Text] [Related]
10. In vivo NMR studies of the glutamate neurotransmitter flux and neuroenergetics: implications for brain function.
Rothman DL; Behar KL; Hyder F; Shulman RG
Annu Rev Physiol; 2003; 65():401-27. PubMed ID: 12524459
[TBL] [Abstract][Full Text] [Related]
11. In vivo quantification of neuro-glial metabolism and glial glutamate concentration using 1H-[13C] MRS at 14.1T.
Lanz B; Xin L; Millet P; Gruetter R
J Neurochem; 2014 Jan; 128(1):125-39. PubMed ID: 24117599
[TBL] [Abstract][Full Text] [Related]
12. Effects of repeated dizocilpine treatment on glutamatergic activity in the prefrontal cortex in an animal model of schizophrenia: An in vivo proton magnetic resonance spectroscopy study at 9.4T.
Yoo CH; Song KH; Lim SI; Lee DW; Woo DC; Choe BY
Neurosci Lett; 2017 Jan; 637():57-63. PubMed ID: 27894920
[TBL] [Abstract][Full Text] [Related]
13. Increased prefrontal and hippocampal glutamate concentration in schizophrenia: evidence from a magnetic resonance spectroscopy study.
van Elst LT; Valerius G; Büchert M; Thiel T; Rüsch N; Bubl E; Hennig J; Ebert D; Olbrich HM
Biol Psychiatry; 2005 Nov; 58(9):724-30. PubMed ID: 16018980
[TBL] [Abstract][Full Text] [Related]
14. Beyond static measures: A review of functional magnetic resonance spectroscopy and its potential to investigate dynamic glutamatergic abnormalities in schizophrenia.
Jelen LA; King S; Mullins PG; Stone JM
J Psychopharmacol; 2018 May; 32(5):497-508. PubMed ID: 29368979
[TBL] [Abstract][Full Text] [Related]
15. What have we learned from proton magnetic resonance spectroscopy about schizophrenia? A critical update.
Abbott C; Bustillo J
Curr Opin Psychiatry; 2006 Mar; 19(2):135-9. PubMed ID: 16612192
[TBL] [Abstract][Full Text] [Related]
16. Nature of Glutamate Alterations in Schizophrenia: A Meta-analysis of Proton Magnetic Resonance Spectroscopy Studies.
Merritt K; Egerton A; Kempton MJ; Taylor MJ; McGuire PK
JAMA Psychiatry; 2016 Jul; 73(7):665-74. PubMed ID: 27304221
[TBL] [Abstract][Full Text] [Related]
17. In Vivo Brain Glycine and Glutamate Concentrations in Patients With First-Episode Psychosis Measured by Echo Time-Averaged Proton Magnetic Resonance Spectroscopy at 4T.
Kim SY; Kaufman MJ; Cohen BM; Jensen JE; Coyle JT; Du F; Öngür D
Biol Psychiatry; 2018 Mar; 83(6):484-491. PubMed ID: 29031411
[TBL] [Abstract][Full Text] [Related]
18. Elevated Myo-Inositol, Choline, and Glutamate Levels in the Associative Striatum of Antipsychotic-Naive Patients With First-Episode Psychosis: A Proton Magnetic Resonance Spectroscopy Study With Implications for Glial Dysfunction.
Plitman E; de la Fuente-Sandoval C; Reyes-Madrigal F; Chavez S; Gómez-Cruz G; León-Ortiz P; Graff-Guerrero A
Schizophr Bull; 2016 Mar; 42(2):415-24. PubMed ID: 26320195
[TBL] [Abstract][Full Text] [Related]
19. Evidence for glutamatergic neuronal dysfunction in the prefrontal cortex in chronic but not in first-episode patients with schizophrenia: a proton magnetic resonance spectroscopy study.
Ohrmann P; Siegmund A; Suslow T; Spitzberg K; Kersting A; Arolt V; Heindel W; Pfleiderer B
Schizophr Res; 2005 Mar; 73(2-3):153-7. PubMed ID: 15653258
[TBL] [Abstract][Full Text] [Related]
20. Brain metabolite alterations in young adults at familial high risk for schizophrenia using proton magnetic resonance spectroscopy.
Tandon N; Bolo NR; Sanghavi K; Mathew IT; Francis AN; Stanley JA; Keshavan MS
Schizophr Res; 2013 Aug; 148(1-3):59-66. PubMed ID: 23791389
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
